Amoy Diagnostics Co Ltd - Company Profile

Powered by

All the data and insights you need on Amoy Diagnostics Co Ltd in one report.

  • Save hours of research time and resources with
    our up-to-date Amoy Diagnostics Co Ltd Strategy Report

  • Understand Amoy Diagnostics Co Ltd position in the market,
    performance and strategic initiatives.

  • Gain competitive edge and increase your
    chances of success

Back to companies

Amoy Diagnostics Co Ltd: Overview

Amoy Diagnostics Co Ltd (AmoyDx) is a pharmaceutical company that develops molecular diagnostics for oncology precision medicine. The company's product portfolio comprises single-gene testing kits, multi-gene testing panels, NGS panels and NGS analytical systems among others. It serves the domestic and international oncology sectors. AmoyDx partners with AstraZeneca, Johnson & Johnson, Amgen, Eli Lilly, Merck, Eisai, Hengrui and BeiGene for trials of drugs in clinical development and for clinical practice. The company markets its products through a network of distributors in Taiwan, Hong Kong, Bangkok, the Philippines and Malaysia among others. AmoyDx is headquartered in Xiamen, Fujian, China.

Gain a 360-degree view of Amoy Diagnostics Co Ltd and make more informed decisions for your business Gain a 360-degree view of Amoy Diagnostics Co Ltd and make more informed decisions for your business Find out more
Headquarters China

Address No.39, Dingshan Road, Haicang District, Xiamen, Fujian, 361027


Telephone 86 592 6806830

No of Employees 1,101

Industry Medical Equipment

Ticker Symbol & Exchange 300685 (SHE)

Revenue (2022) $125.2M -8.2% (2022 vs 2021)

EPS XYZ

Net Income (2022) XYZ 10.1% (2022 vs 2021)

Market Cap* $1.2B

Net Profit Margin (2022) XYZ 19.9% (2022 vs 2021)

* As of and is in US$
Gain access to our premium signals and make informed decisions for your business Gain access to our premium signals and make informed decisions for your business Find out more

Amoy Diagnostics Co Ltd premium industry data and analytics

11+

Medical Pipeline Products

A database of medical devices that are in the process to get approved for sale around the world. Devices that are in development, through to those in the approval process are included.

10+

Medical Clinical Trials

A database of clinical trials planned, currently ongoing, completed, suspended, withdrawn, and terminated in countries around the world.

1

ICT Spend & Tech Priorities

IT Client Prospector provides intelligence on Amoy Diagnostics Co Ltd’s likely spend across technology areas enabling you to understand the digital strategy.

Products and Services

Products Brands
Diagnostic Assays ADx-ARMS
Single-Gene Testing Kits Super-ARMS
NGS Analytical Systems ddCapture
XYZ XYZ
XYZ XYZ
XYZ XYZ
Understand Amoy Diagnostics Co Ltd portfolio and identify potential areas for collaboration Understand Amoy Diagnostics Co Ltd portfolio and identify potential areas for collaboration Find out more

History

History section provides information on new products, mergers, acquisitions, expansions, approvals, and many more key events.

Year Event Description
2023 Contracts/Agreements In November, the company entered into multiple collaborations with AstraZeneca and Pfizer to promote the development of precision diagnostics and treatment benefiting cancer patients.
2023 Contracts/Agreements In July, the company entered into a collaboration with Astrazeneca for HRD companion Diagnostic.
2023 Regulatory Approval In April, the company received approval from the Ministry of Health, Labor and Welfare of Japan for a polymerase chain reaction-based pan-lung cancer (PLC) panel.
Dive into past operations, including product releases, deals, acquisitions & more Dive into past operations, including product releases, deals, acquisitions & more Find out more
Image for loader

Competitor Comparison

Key Parameters Amoy Diagnostics Co Ltd Shanghai Kehua Bio-engineering Co Ltd Guangzhou Wondfo Biotech Co Ltd Beijing Strong Biotechnologies Inc Dirui Industrial Co Ltd
Headquarters China China China China China
City Xiamen Shanghai Guangzhou Beijing Changchun
State/Province Fujian Shanghai Guangdong Beijing Jilin
No. of Employees 1,101 2,709 3,459 1,094 1,879
Entity Type Public Public Public Public Public
Benchmark the company against the market with exclusive information on key competitors Benchmark the company against the market with exclusive information on key competitors Find out more
Chart Financial activity with access to more key stats Chart Financial activity with access to more key stats Find out more
Executives
Name Position Board Since Age
Li-Mou Zheng Chairman Executive Board 2015 70
Ruan Li Deputy General Manager; Director Executive Board 2015 45
Frank Ron Zheng Director; Deputy General Manager Executive Board 2021 33
Luo Jimin General Manager - Rotating; Director Executive Board - -
Chen Ying Secretary; Chief Financial Officer Senior Management 2015 53
Non Dignissim Eros Proin vel Convallis 2024 XY
Non Dignissim Eros Proin vel Convallis 2024 XY
Non Dignissim Eros Proin vel Convallis 2024 XY
Gain insight into Amoy Diagnostics Co Ltd key executives to enhance your sales strategy Gain insight into Amoy Diagnostics Co Ltd key executives to enhance your sales strategy Find out more
Still looking?

Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.

Explorer

Access more premium companies when you subscribe to Explorer

Get in touch about GlobalData Company reports

Contact the team or request a demo to find out how our data can drive your business forward